The recommendation was given by the panel after assessing the data of phase 1 and 2 clinical trials as well as animal challenge study.
from Latest News https://www.dnaindia.com/india/report-covid-19-vaccine-update-dgci-panel-gives-nod-to-phase-3-trials-of-bharat-biotech-s-covaxin-2851740
Thursday, October 22, 2020
Home »
Latest News
,
News
» COVID-19 vaccine update: DGCI panel gives nod to phase 3 trials of Bharat Biotech's Covaxin
0 comments:
Post a Comment